Clinical trials
Australian-made device by muPharma uses ultrasound to non-invasively deliver eye therapies
Melbourne biotech company muPharma, founded by ophthalmologist Dr Harry Unger and Mr Mark Unger, has developed an investigational device that...
Read more
Study to shed light on combined effect of multifocal contact lenses and atropine on myopia
Much effort is going into understanding the impact of combined treatments for myopia management, but little is known about the...
Read more
Iveric Bio reveals vision loss reduction data in investigational geographic atrophy therapy
US biopharmaceutical company Iveric Bio has released new data for its avacincaptad pegol (ACP) therapy for geographic atrophy (GA), which...
Read more
How Glaukos iDose TR performed in latest glaucoma trial
Glaukos announced positive results from a trial evaluating the safety of the surgical exchange procedure for its iDose TR (travoprost...
Read more
SLT vs eye drops: LiGHT glaucoma trial publishes six-year findings
The landmark LiGHT (Laser in Glaucoma and Ocular Hypertension Trial) study – that ultimately recommended selective laser trabeculoplasty (SLT) as...
Read more
Aussie myopia study reveals who benefits the most from low-dose atropine
Ancestry may be a factor in the effectiveness of low-dose atropine eye drops for myopia control, according to an Australian-first...
Read more
Aflibercept 8mg could become AMD standard-of-care after pivotal trial
The drug company that produces Eylea (2 mg aflibercept) has announced clinical trial results showing the anti-VEGF therapy can be...
Read more
Longer-acting implant may be better for Aboriginal DMO patients – study
A pioneering study out of Western Australia has shown that a longer acting intravitreal dexamethasone implant (DEX-implant) may lead to...
Read more